Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -5.34 | -16.22 |
PEG Ratio (TTM) | -1.58 | -1.41 |
P/S Ratio (TTM) | -30.34 | 48.82 |
P/B Ratio (TTM) | 9.00 | 21.13 |
P/FCF Ratio (TTM) | -8.60 | 9.38 |
Price to 5YR AVG Earnings Ratio | N/A | -0.21 |
Price to 5YR AVG FCF Ratio | N/A | -7.10 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -115.32% | -3.10% |
ROE (TTM) | -152.26% | 24.21% |
Net Profit Margin (TTM) | 514.56% | -1,069.78% |
ROIC 5YR AVG | N/A | 16.50% |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 7.54% | -42,064.39% | N/A |
Revenue | -25.00% | -33.33% | N/A |
Net Income | 3.81% | -42,941.43% | N/A |
Cash Flow | 4.84% | -13,253.44% | N/A |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.17 | 5.75 |
Quick Ratio (TTM) | 3.17 | 5.47 |
D/E Ratio (TTM) | N/A | -15.13 |
Interest Coverage (TTM) | -424.29 | 3.59 |
Piotroski F-Score | 1 | 5 |
Altman Z-Score | 6.04 | 13.47 |
LTL to 5YR AVG FCF | N/A | 0.20 |
Shares Outstanding Growth 5YR AVG | N/A | 118.86% |